Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Adaptive Biotechnologies Corporation    ADPT

ADAPTIVE BIOTECHNOLOGIES CORPORATION

(ADPT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Adaptive Biotechnologies Corporation : half-yearly earnings release

08/05/2020 | 09:15am EST

The company will report its earnings for S1 2020 on 08/10/2020. Generally, the company reports earnings worse than estimates. In recent months, the 4 analysts from Standard & Poor's consensus have not revised their EPS estimates.


© MarketScreener.com 2020
All news about ADAPTIVE BIOTECHNOLOGIES CORPORATION
11/24ADAPTIVE BIOTECHNOLOGIES : and Collaborators to Present Data from More Than 35 A..
AQ
11/23ADAPTIVE BIOTECHNOLOGIES : and Collaborators to Present Data from More Than 35 A..
AQ
11/23Adaptive Biotechnologies and Collaborators to Present Data from More Than 35 ..
GL
11/16ADAPTIVE BIOTECHNOLOGIES : Preliminary Data from Real-World Study Demonstrate T-..
AQ
11/13ADAPTIVE BIOTECHNOLOGIES : Preliminary Data from Real-World Study Demonstrate T-..
AQ
11/13Preliminary Data from Real-World Study Demonstrate T-cell Testing Outperforms..
GL
11/12ADAPTIVE BIOTECHNOLOGIES CORP : Other Events (form 8-K)
AQ
11/10ADAPTIVE BIOTECHNOLOGIES : Management's Discussion and Analysis of Financial Con..
AQ
11/10ADAPTIVE BIOTECHNOLOGIES CORP : Results of Operations and Financial Condition, F..
AQ
11/10ADAPTIVE BIOTECHNOLOGIES : 3Q Earnings Snapshot
AQ
More news
Financials (USD)
Sales 2020 94,8 M - -
Net income 2020 -142 M - -
Net cash 2020 509 M - -
P/E ratio 2020 -42,4x
Yield 2020 -
Capitalization 6 268 M 6 268 M -
EV / Sales 2020 60,7x
EV / Sales 2021 36,0x
Nbr of Employees 453
Free-Float 94,2%
Chart ADAPTIVE BIOTECHNOLOGIES CORPORATION
Duration : Period :
Adaptive Biotechnologies Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ADAPTIVE BIOTECHNOLOGIES CORPORATION
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 8
Average target price 58,17 $
Last Close Price 45,83 $
Spread / Highest target 44,0%
Spread / Average Target 26,9%
Spread / Lowest Target 0,37%
EPS Revisions
Managers
NameTitle
Chad Robins Chairman & Chief Executive Officer
Julie Rubinstein President
Nancy L. Hill Senior Vice President-Operations
Chad M. Cohen CFO, Principal Financial & Accounting Officer
Harlan Robins Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
ADAPTIVE BIOTECHNOLOGIES CORPORATION53.18%6 268
EXACT SCIENCES CORPORATION25.29%18 427
GUARDANT HEALTH, INC.44.15%11 261
INVITAE CORPORATION190.45%8 278
IOVANCE BIOTHERAPEUTICS, INC.34.25%5 565
SEEGENE INC--.--%4 171